Michal Zikan Selected Research

Endometrial Stromal Sarcoma

3/2017

Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Zikan Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 03/2005
10	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 11/2010
8	Breast Neoplasms (Breast Cancer) 09/2023 - 02/2007
5	Lymphocele 03/2019 - 03/2014
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 05/2009
2	Toxoplasmosis 01/2024 - 01/2022
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 11/2013
1	Carcinoma in Situ 03/2024
1	Carcinogenesis 03/2024
1	Lung Neoplasms (Lung Cancer) 03/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2024
1	Lymphoma (Lymphomas) 03/2024
1	Myalgia 01/2023
1	Chronic Pain 01/2023
1	Dyspareunia 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Ascites 06/2020
1	Inflammation (Inflammations) 01/2019
1	Endometriosis 12/2017
1	Circulating Neoplastic Cells 12/2017
1	Sarcoma (Soft Tissue Sarcoma) 03/2017
1	Leiomyosarcoma 03/2017
1	Adenosarcoma 03/2017
1	Endometrial Stromal Sarcoma 03/2017
1	Smooth Muscle Tumor 03/2017
1	Pain (Aches) 05/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2015
1	Lymphedema (Milroy Disease) 05/2015
1	Hydronephrosis 05/2015
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2011
1	Carcinoma (Carcinomatosis) 01/2011
1	Neoplasm Metastasis (Metastasis) 01/2010
1	Aneuploidy (Aneuploid) 07/2007

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2009
3	Cell-Free Nucleic AcidsIBA 10/2023 - 12/2017
3	Hormones (Hormone)IBA 09/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 12/2017 - 11/2013
2	Immunoglobulin M (IgM)IBA 01/2024 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2022
2	A-Form DNA (A-DNA)IBA 01/2022 - 01/2014
2	FibrinIBA 01/2018 - 08/2014
2	CollagenIBA 01/2018 - 08/2014
1	Growth Factor ReceptorsIBA 03/2024
1	PlatinumIBA 04/2023
1	Pain-FreeIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2019
1	Suppositories (Vaginal Suppositories)IBA 01/2019
1	hydrogen sulfite (bisulfite)IBA 12/2017
1	Circulating Tumor DNAIBA 12/2017
1	Docetaxel (Taxotere)FDA Link 12/2017
1	Gemcitabine FDA Link 12/2017
1	Diphosphonates (Bisphosphonates)IBA 12/2017
1	Ribosomal Proteins (Ribosomal Protein)IBA 03/2017
1	Transcription Factors (Transcription Factor)IBA 11/2013
1	EnzymesIBA 02/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011
1	Combined Oral ContraceptivesIBA 08/2011
1	Oral ContraceptivesIBA 08/2011
1	5' Untranslated Regions (5' UTR)IBA 12/2007
1	Aurora Kinase AIBA 07/2007
1	Coloring Agents (Dyes)IBA 02/2007
1	Nonsense Codon (Nonsense Mutation)IBA 03/2005

Therapy/Procedure

7	Lymph Node Excision (Lymph Node Dissection) 03/2019 - 01/2011
2	Laparotomy 06/2020 - 03/2014
2	Neoadjuvant Therapy 12/2017 - 01/2016
2	Trachelectomy 01/2017 - 01/2016
2	Radiotherapy 01/2017 - 03/2014
1	Breast Implants (Breast Implant) 03/2024
1	Therapeutics 01/2023
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2022
1	Punctures 06/2020
1	Tubal Sterilization (Tubal Ligation) 01/2019
1	Drug Therapy (Chemotherapy) 12/2017
1	Adjuvant Chemotherapy 12/2017
1	Hysterectomy 05/2015
1	Salpingo-oophorectomy 08/2011
1	Chemoprevention 08/2011
1	Ligation 11/2010
1	Injections 02/2007